Loading...

PE anti-mouse CD4 Antibody PE anti-mouse CD4 Antibody

Pricing & Availability
Clone
GK1.5 (See other available formats)
Regulatory Status
RUO
Other Names
L3T4, T4
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
1_GK1dot5_PE_021706
C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram).
  • 1_GK1dot5_PE_021706
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram).
  • 2_GK15_PE_CD4_Antibody_2_040122
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) PE (solid line) or rat IgG2b, κ PE isotype control (dashed line).
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
100407 50 µg NOK207
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100408 200 µg NOK594
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4 is a 55 kD protein also known as L3T4 or T4. It is a member of the Ig superfamily, primarily expressed on most thymocytes, a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a coreceptor with the TCR during T cell activation and thymic differentiation by binding MHC class II and associating with the protein tyrosin kinase, lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation. Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Application References
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  2. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  3. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  4. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  5. Friess MC, et al. 2022. Cell Rep. 38:110334. PubMed
  6. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  7. Kawai H, et al. 2021. Asian Pac J Allergy Immunol. :. PubMed
  8. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  9. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  10. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  11. Man SM et al. 2016. Cell. 167(2):382-396 . PubMed
  12. Zveik O, et al. 2022. Glia. 70:1191. PubMed
  13. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  14. Zhou H, et al. 2022. EMBO Rep. 23:e53791. PubMed
  15. Grebinoski S, et al. 2022. Nat Immunol. 23:868. PubMed
  16. Merana GR, et al. 2022. Cell Rep. 39:110891. PubMed
  17. Guo X, et al. 2022. Invest Ophthalmol Vis Sci. 63:12. PubMed
  18. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  19. Shen CY, et al. 2022. Pharmaceutics. 14: . PubMed
  20. Millar FR, et al. 2022. Cell Rep. 41:111596. PubMed
  21. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  22. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  23. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  24. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  25. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  26. Wang L, et al. 2022. Nutrients. 15: . PubMed
  27. Glaubitz J, et al. 2023. Gut. :. PubMed
  28. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  29. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  30. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  31. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  32. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  33. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  34. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  35. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  36. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  37. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  38. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  39. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  40. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  41. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  42. Guo X, et al. 2023. Mol Immunol. 160:32. PubMed
  43. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  44. Feola S, et al. 2022. Front Immunol. 13:826164. PubMed
  45. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  46. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  47. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  48. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  49. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  50. Willinger T, et al. 2014. J Exp Med. 211:685. PubMed
  51. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  52. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  53. Zhang L, et al. 2020. Front Oncol. 1.243055556. PubMed
  54. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  55. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  56. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  57. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  58. Leech JM, et al. 2020. Cell Host & Microbe. 26(6):795-809.e5.. PubMed
  59. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  60. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  61. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  62. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  63. Isoda T et al. 2017. Cell. 171(1):103-119 . PubMed
  64. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  65. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  66. Yuan X, et al. 2019. JCI Insight. 4:e124317. PubMed
  67. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  68. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  69. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  70. Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed
  71. Pérez‐Mazliah D et al. 2017. EBioMedicine. 24:216-230 . PubMed
  72. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  73. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  74. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  75. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  76. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  77. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  78. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  79. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  80. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  81. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  82. Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed
  83. Sato K, et al. 2015. PLoS One. 10: 0138291. PubMed
  84. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  85. Karki R, et al. 2020. JCI Insight. 5:00. PubMed
  86. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  87. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  88. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  89. Collin R, et al. 2014. J Immunol. 193:3503. PubMed
  90. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  91. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  92. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  93. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  94. Lv F, et al. 2022. iScience. 25:103639. PubMed
  95. Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed
  96. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  97. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  98. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  99. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  100. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  101. Yang H, et al. 2022. Nutrients. 14:. PubMed
  102. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  103. Huang YL, et al. 2021. Commun Biol. 4:229. PubMed
  104. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  105. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  106. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  107. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  108. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  109. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  110. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  111. Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed
  112. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  113. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  114. Shen X, et al. 2021. Front Immunol. 12:710750. PubMed
  115. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  116. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  117. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  118. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  119. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  120. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  121. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  122. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  123. Yang C, et al. 2013. Proc Natl Acad Sci U S A. 111:109. PubMed
  124. Du J, et al. 2018. AMB Express. 8:158. PubMed
  125. Cho K, et al. 2021. iScience. 24:103117. PubMed
  126. Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed
  127. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  128. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  129. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  130. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  131. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  132. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  133. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  134. Matsuo K, et al. 2018. J Immunol. 200:800. PubMed
  135. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  136. Andrade ACDSP, et al. 2021. J Virol. 95:e0127621. PubMed
  137. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  138. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  139. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  140. Liyanage S, et al. 2016. Exp Eye Res. 151:160-70. PubMed
  141. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  142. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  143. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  144. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  145. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  146. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  147. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  148. Nakamura Y, et al. 2015. Infect Immun . 83:671. PubMed
  149. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  150. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  151. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  152. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  153. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  154. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  155. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  156. Zhang H, et al. 2009. Invest Ophthalmol Vis Sci. 50:2653. PubMed
  157. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  158. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  159. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  160. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  161. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  162. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  163. Liu Y, et al. 2019. Sci Rep. 9:18970. PubMed
  164. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  165. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  166. Wang J, et al. 2019. Aging (Albany NY). 11:3463. PubMed
  167. Chen S, et al. 2022. iScience. 25:105176. PubMed
  168. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  169. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  170. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  171. Pantelidou C, et al. 2022. NPJ Breast Cancer. 8:102. PubMed
  172. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  173. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  174. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  175. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  176. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  177. Mahlios J, Zhuang Y 2011. Mol Immunol. 49:227. PubMed
  178. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  179. Klose R, et al. 2016. Nat Commun. 7:12528. PubMed
  180. Yomogida K, et al. 2013. Biochem Biophys Res Commun. 434:263. PubMed
  181. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  182. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  183. Li H, et al. 2022. iScience. 25:104481. PubMed
  184. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  185. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  186. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  187. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  188. Gao P, et al. 2021. Nat Commun. 1194:12. PubMed
  189. Yeon S, et al. 2017. Sci Rep. 10.1038/s41598-017-11492-7. PubMed
  190. Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed
  191. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  192. Pflügler S, et al. 2020. Commun Biol. 3:252. PubMed
  193. Rudd CE, et al. 2020. Cell Reports. 30(7):2075-2082. PubMed
  194. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  195. Petty AJ, et al. 2021. JCI Insight. 6:. PubMed
  196. Gawish R, et al. 2022. Elife. 11:. PubMed
  197. Kong IY, et al. 2020. Cell Rep. 33:108290. PubMed
  198. Fu W, et al. 2020. J Immunol Res. 8820355:2020. PubMed
  199. Sun J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:15:00. PubMed
  200. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  201. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  202. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  203. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  204. Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
  205. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  206. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  207. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  208. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  209. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  210. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  211. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  212. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  213. Friess MC, et al. 2022. Cell Rep. 38:110334. PubMed
  214. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  215. Kawai H, et al. 2021. Asian Pac J Allergy Immunol. :. PubMed
  216. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  217. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  218. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  219. Man SM et al. 2016. Cell. 167(2):382-396 . PubMed
  220. Zveik O, et al. 2022. Glia. 70:1191. PubMed
  221. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  222. Zhou H, et al. 2022. EMBO Rep. 23:e53791. PubMed
  223. Grebinoski S, et al. 2022. Nat Immunol. 23:868. PubMed
  224. Merana GR, et al. 2022. Cell Rep. 39:110891. PubMed
  225. Guo X, et al. 2022. Invest Ophthalmol Vis Sci. 63:12. PubMed
  226. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  227. Shen CY, et al. 2022. Pharmaceutics. 14: . PubMed
  228. Millar FR, et al. 2022. Cell Rep. 41:111596. PubMed
  229. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  230. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  231. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  232. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  233. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  234. Wang L, et al. 2022. Nutrients. 15: . PubMed
  235. Glaubitz J, et al. 2023. Gut. :. PubMed
  236. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  237. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  238. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  239. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  240. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  241. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  242. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  243. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  244. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  245. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  246. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  247. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  248. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  249. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  250. Guo X, et al. 2023. Mol Immunol. 160:32. PubMed
  251. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  252. Feola S, et al. 2022. Front Immunol. 13:826164. PubMed
  253. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  254. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  255. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  256. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  257. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  258. Willinger T, et al. 2014. J Exp Med. 211:685. PubMed
  259. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  260. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  261. Zhang L, et al. 2020. Front Oncol. 1.243055556. PubMed
  262. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  263. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  264. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  265. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  266. Leech JM, et al. 2020. Cell Host & Microbe. 26(6):795-809.e5.. PubMed
  267. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  268. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  269. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  270. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  271. Isoda T et al. 2017. Cell. 171(1):103-119 . PubMed
  272. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  273. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  274. Yuan X, et al. 2019. JCI Insight. 4:e124317. PubMed
  275. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  276. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  277. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  278. Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed
  279. Pérez‐Mazliah D et al. 2017. EBioMedicine. 24:216-230 . PubMed
  280. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  281. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  282. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  283. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  284. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  285. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  286. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  287. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  288. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  289. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  290. Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed
  291. Sato K, et al. 2015. PLoS One. 10: 0138291. PubMed
  292. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  293. Karki R, et al. 2020. JCI Insight. 5:00. PubMed
  294. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  295. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  296. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  297. Collin R, et al. 2014. J Immunol. 193:3503. PubMed
  298. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  299. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  300. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  301. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  302. Lv F, et al. 2022. iScience. 25:103639. PubMed
  303. Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed
  304. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  305. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  306. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  307. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  308. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  309. Yang H, et al. 2022. Nutrients. 14:. PubMed
  310. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  311. Huang YL, et al. 2021. Commun Biol. 4:229. PubMed
  312. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  313. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  314. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  315. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  316. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  317. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  318. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  319. Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed
  320. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  321. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  322. Shen X, et al. 2021. Front Immunol. 12:710750. PubMed
  323. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  324. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  325. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  326. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  327. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  328. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  329. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  330. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  331. Yang C, et al. 2013. Proc Natl Acad Sci U S A. 111:109. PubMed
  332. Du J, et al. 2018. AMB Express. 8:158. PubMed
  333. Cho K, et al. 2021. iScience. 24:103117. PubMed
  334. Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed
  335. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  336. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  337. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  338. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  339. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  340. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  341. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  342. Matsuo K, et al. 2018. J Immunol. 200:800. PubMed
  343. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  344. Andrade ACDSP, et al. 2021. J Virol. 95:e0127621. PubMed
  345. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  346. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  347. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  348. Liyanage S, et al. 2016. Exp Eye Res. 151:160-70. PubMed
  349. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  350. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  351. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  352. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  353. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  354. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  355. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  356. Nakamura Y, et al. 2015. Infect Immun . 83:671. PubMed
  357. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  358. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  359. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  360. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  361. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  362. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  363. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  364. Zhang H, et al. 2009. Invest Ophthalmol Vis Sci. 50:2653. PubMed
  365. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  366. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  367. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  368. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  369. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  370. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  371. Liu Y, et al. 2019. Sci Rep. 9:18970. PubMed
  372. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  373. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  374. Wang J, et al. 2019. Aging (Albany NY). 11:3463. PubMed
  375. Chen S, et al. 2022. iScience. 25:105176. PubMed
  376. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  377. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  378. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  379. Pantelidou C, et al. 2022. NPJ Breast Cancer. 8:102. PubMed
  380. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  381. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  382. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  383. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  384. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  385. Mahlios J, Zhuang Y 2011. Mol Immunol. 49:227. PubMed
  386. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  387. Klose R, et al. 2016. Nat Commun. 7:12528. PubMed
  388. Yomogida K, et al. 2013. Biochem Biophys Res Commun. 434:263. PubMed
  389. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  390. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  391. Li H, et al. 2022. iScience. 25:104481. PubMed
  392. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  393. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  394. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  395. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  396. Gao P, et al. 2021. Nat Commun. 1194:12. PubMed
  397. Yeon S, et al. 2017. Sci Rep. 10.1038/s41598-017-11492-7. PubMed
  398. Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed
  399. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  400. Pflügler S, et al. 2020. Commun Biol. 3:252. PubMed
  401. Rudd CE, et al. 2020. Cell Reports. 30(7):2075-2082. PubMed
  402. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  403. Petty AJ, et al. 2021. JCI Insight. 6:. PubMed
  404. Gawish R, et al. 2022. Elife. 11:. PubMed
  405. Kong IY, et al. 2020. Cell Rep. 33:108290. PubMed
  406. Fu W, et al. 2020. J Immunol Res. 8820355:2020. PubMed
  407. Sun J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:15:00. PubMed
  408. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  409. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  410. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  411. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  412. Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
  413. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  414. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  415. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  416. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
RRID
AB_312692 (BioLegend Cat. No. 100407)
AB_312693 (BioLegend Cat. No. 100408)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.
What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD4 Reagents Request Custom Conjugation
Description Clone Applications
APC/Cyanine7 anti-mouse CD4 GK1.5 FC
Brilliant Violet 711™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 510™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 605™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 785™ anti-mouse CD4 GK1.5 FC
PE/Dazzle™ 594 anti-mouse CD4 GK1.5 FC
APC/Fire™ 750 anti-mouse CD4 GK1.5 FC
GoInVivo™ Purified anti-mouse CD4 GK1.5 FC
Brilliant Violet 750™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 650™ anti-mouse CD4 GK1.5 FC
Spark Blue™ 550 anti-mouse CD4 GK1.5 FC
Spark NIR™ 685 anti-mouse CD4 GK1.5 FC
KIRAVIA Blue 520™ anti-mouse CD4 GK1.5 FC
APC/Fire™ 810 anti-mouse CD4 GK1.5 FC
PE/Fire™ 700 anti-mouse CD4 GK1.5 FC
PE/Fire™ 640 anti-mouse CD4 GK1.5 FC
APC anti-mouse CD4 GK1.5 FC
Biotin anti-mouse CD4 GK1.5 FC,IHC-F,ICC
FITC anti-mouse CD4 GK1.5 FC
PE anti-mouse CD4 GK1.5 FC
PE/Cyanine5 anti-mouse CD4 GK1.5 FC
Purified anti-mouse CD4 GK1.5 FC,IHC-F,ICC,IP,Costim,Block,Depletion
Alexa Fluor® 647 anti-mouse CD4 GK1.5 FC,IHC-F
Alexa Fluor® 488 anti-mouse CD4 GK1.5 FC,IHC-F
Alexa Fluor® 700 anti-mouse CD4 GK1.5 FC
Pacific Blue™ anti-mouse CD4 GK1.5 FC
PerCP anti-mouse CD4 GK1.5 FC
PerCP/Cyanine5.5 anti-mouse CD4 GK1.5 FC
Brilliant Violet 421™ anti-mouse CD4 GK1.5 FC,ICC,IHC-F
Ultra-LEAF™ Purified anti-mouse CD4 GK1.5 FC,Block,Costim,Depletion,IHC,IP
Alexa Fluor® 594 anti-mouse CD4 GK1.5 IHC-F,FC,SB
Spark Violet™ 538 anti-mouse CD4 GK1.5 FC
Spark YG™ 593 anti-mouse CD4 GK1.5 FC
Spark Blue™ 574 anti-mouse CD4 Antibody GK1.5 FC
Spark UV™ 387 anti-mouse CD4 GK1.5 FC
Spark Blue™ 515 anti-mouse CD4 GK1.5 FC
Spark PLUS UV395™ anti-mouse CD4 GK1.5 FC
Spark Red™ 718 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
PerCP/Fire™ 806 anti-mouse CD4 Antibody GK1.5 FC
PerCP/Fire™ 780 anti-mouse CD4 Antibody GK1.5 FC
StarBright UltraViolet 795 anti-mouse CD4 GK1.5 FC
Spark PLUS V475™ anti-mouse CD4 GK1.5 FC
Spark YG™ 581 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
Spark PLUS B488™ anti-mouse CD4 GK1.5 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
GK1.5 (See other available formats)
Regulatory Status
RUO
Other Names
L3T4, T4
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
1_GK1dot5_PE_021706
C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram).
  • 1_GK1dot5_PE_021706
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram).
  • 2_GK15_PE_CD4_Antibody_2_040122
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) PE (solid line) or rat IgG2b, κ PE isotype control (dashed line).
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
100407 50 µg NOK207
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100408 200 µg NOK594
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4 is a 55 kD protein also known as L3T4 or T4. It is a member of the Ig superfamily, primarily expressed on most thymocytes, a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a coreceptor with the TCR during T cell activation and thymic differentiation by binding MHC class II and associating with the protein tyrosin kinase, lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation. Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Application References
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  2. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  3. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  4. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  5. Friess MC, et al. 2022. Cell Rep. 38:110334. PubMed
  6. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  7. Kawai H, et al. 2021. Asian Pac J Allergy Immunol. :. PubMed
  8. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  9. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  10. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  11. Man SM et al. 2016. Cell. 167(2):382-396 . PubMed
  12. Zveik O, et al. 2022. Glia. 70:1191. PubMed
  13. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  14. Zhou H, et al. 2022. EMBO Rep. 23:e53791. PubMed
  15. Grebinoski S, et al. 2022. Nat Immunol. 23:868. PubMed
  16. Merana GR, et al. 2022. Cell Rep. 39:110891. PubMed
  17. Guo X, et al. 2022. Invest Ophthalmol Vis Sci. 63:12. PubMed
  18. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  19. Shen CY, et al. 2022. Pharmaceutics. 14: . PubMed
  20. Millar FR, et al. 2022. Cell Rep. 41:111596. PubMed
  21. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  22. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  23. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  24. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  25. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  26. Wang L, et al. 2022. Nutrients. 15: . PubMed
  27. Glaubitz J, et al. 2023. Gut. :. PubMed
  28. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  29. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  30. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  31. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  32. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  33. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  34. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  35. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  36. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  37. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  38. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  39. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  40. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  41. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  42. Guo X, et al. 2023. Mol Immunol. 160:32. PubMed
  43. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  44. Feola S, et al. 2022. Front Immunol. 13:826164. PubMed
  45. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  46. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  47. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  48. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  49. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  50. Willinger T, et al. 2014. J Exp Med. 211:685. PubMed
  51. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  52. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  53. Zhang L, et al. 2020. Front Oncol. 1.243055556. PubMed
  54. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  55. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  56. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  57. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  58. Leech JM, et al. 2020. Cell Host & Microbe. 26(6):795-809.e5.. PubMed
  59. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  60. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  61. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  62. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  63. Isoda T et al. 2017. Cell. 171(1):103-119 . PubMed
  64. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  65. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  66. Yuan X, et al. 2019. JCI Insight. 4:e124317. PubMed
  67. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  68. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  69. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  70. Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed
  71. Pérez‐Mazliah D et al. 2017. EBioMedicine. 24:216-230 . PubMed
  72. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  73. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  74. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  75. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  76. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  77. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  78. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  79. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  80. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  81. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  82. Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed
  83. Sato K, et al. 2015. PLoS One. 10: 0138291. PubMed
  84. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  85. Karki R, et al. 2020. JCI Insight. 5:00. PubMed
  86. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  87. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  88. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  89. Collin R, et al. 2014. J Immunol. 193:3503. PubMed
  90. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  91. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  92. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  93. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  94. Lv F, et al. 2022. iScience. 25:103639. PubMed
  95. Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed
  96. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  97. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  98. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  99. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  100. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  101. Yang H, et al. 2022. Nutrients. 14:. PubMed
  102. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  103. Huang YL, et al. 2021. Commun Biol. 4:229. PubMed
  104. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  105. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  106. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  107. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  108. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  109. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  110. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  111. Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed
  112. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  113. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  114. Shen X, et al. 2021. Front Immunol. 12:710750. PubMed
  115. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  116. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  117. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  118. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  119. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  120. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  121. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  122. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  123. Yang C, et al. 2013. Proc Natl Acad Sci U S A. 111:109. PubMed
  124. Du J, et al. 2018. AMB Express. 8:158. PubMed
  125. Cho K, et al. 2021. iScience. 24:103117. PubMed
  126. Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed
  127. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  128. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  129. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  130. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  131. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  132. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  133. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  134. Matsuo K, et al. 2018. J Immunol. 200:800. PubMed
  135. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  136. Andrade ACDSP, et al. 2021. J Virol. 95:e0127621. PubMed
  137. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  138. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  139. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  140. Liyanage S, et al. 2016. Exp Eye Res. 151:160-70. PubMed
  141. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  142. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  143. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  144. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  145. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  146. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  147. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  148. Nakamura Y, et al. 2015. Infect Immun . 83:671. PubMed
  149. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  150. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  151. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  152. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  153. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  154. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  155. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  156. Zhang H, et al. 2009. Invest Ophthalmol Vis Sci. 50:2653. PubMed
  157. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  158. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  159. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  160. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  161. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  162. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  163. Liu Y, et al. 2019. Sci Rep. 9:18970. PubMed
  164. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  165. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  166. Wang J, et al. 2019. Aging (Albany NY). 11:3463. PubMed
  167. Chen S, et al. 2022. iScience. 25:105176. PubMed
  168. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  169. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  170. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  171. Pantelidou C, et al. 2022. NPJ Breast Cancer. 8:102. PubMed
  172. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  173. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  174. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  175. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  176. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  177. Mahlios J, Zhuang Y 2011. Mol Immunol. 49:227. PubMed
  178. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  179. Klose R, et al. 2016. Nat Commun. 7:12528. PubMed
  180. Yomogida K, et al. 2013. Biochem Biophys Res Commun. 434:263. PubMed
  181. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  182. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  183. Li H, et al. 2022. iScience. 25:104481. PubMed
  184. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  185. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  186. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  187. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  188. Gao P, et al. 2021. Nat Commun. 1194:12. PubMed
  189. Yeon S, et al. 2017. Sci Rep. 10.1038/s41598-017-11492-7. PubMed
  190. Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed
  191. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  192. Pflügler S, et al. 2020. Commun Biol. 3:252. PubMed
  193. Rudd CE, et al. 2020. Cell Reports. 30(7):2075-2082. PubMed
  194. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  195. Petty AJ, et al. 2021. JCI Insight. 6:. PubMed
  196. Gawish R, et al. 2022. Elife. 11:. PubMed
  197. Kong IY, et al. 2020. Cell Rep. 33:108290. PubMed
  198. Fu W, et al. 2020. J Immunol Res. 8820355:2020. PubMed
  199. Sun J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:15:00. PubMed
  200. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  201. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  202. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  203. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  204. Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
  205. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  206. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  207. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  208. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  209. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  210. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  211. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  212. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  213. Friess MC, et al. 2022. Cell Rep. 38:110334. PubMed
  214. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  215. Kawai H, et al. 2021. Asian Pac J Allergy Immunol. :. PubMed
  216. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  217. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  218. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  219. Man SM et al. 2016. Cell. 167(2):382-396 . PubMed
  220. Zveik O, et al. 2022. Glia. 70:1191. PubMed
  221. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  222. Zhou H, et al. 2022. EMBO Rep. 23:e53791. PubMed
  223. Grebinoski S, et al. 2022. Nat Immunol. 23:868. PubMed
  224. Merana GR, et al. 2022. Cell Rep. 39:110891. PubMed
  225. Guo X, et al. 2022. Invest Ophthalmol Vis Sci. 63:12. PubMed
  226. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  227. Shen CY, et al. 2022. Pharmaceutics. 14: . PubMed
  228. Millar FR, et al. 2022. Cell Rep. 41:111596. PubMed
  229. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  230. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  231. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  232. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  233. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  234. Wang L, et al. 2022. Nutrients. 15: . PubMed
  235. Glaubitz J, et al. 2023. Gut. :. PubMed
  236. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  237. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  238. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  239. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  240. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  241. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  242. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  243. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  244. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  245. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  246. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  247. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  248. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  249. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  250. Guo X, et al. 2023. Mol Immunol. 160:32. PubMed
  251. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  252. Feola S, et al. 2022. Front Immunol. 13:826164. PubMed
  253. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  254. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  255. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  256. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  257. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  258. Willinger T, et al. 2014. J Exp Med. 211:685. PubMed
  259. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  260. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  261. Zhang L, et al. 2020. Front Oncol. 1.243055556. PubMed
  262. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  263. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  264. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  265. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  266. Leech JM, et al. 2020. Cell Host & Microbe. 26(6):795-809.e5.. PubMed
  267. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  268. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  269. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  270. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  271. Isoda T et al. 2017. Cell. 171(1):103-119 . PubMed
  272. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  273. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  274. Yuan X, et al. 2019. JCI Insight. 4:e124317. PubMed
  275. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  276. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  277. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  278. Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed
  279. Pérez‐Mazliah D et al. 2017. EBioMedicine. 24:216-230 . PubMed
  280. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  281. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  282. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  283. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  284. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  285. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  286. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  287. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  288. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  289. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  290. Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed
  291. Sato K, et al. 2015. PLoS One. 10: 0138291. PubMed
  292. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  293. Karki R, et al. 2020. JCI Insight. 5:00. PubMed
  294. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  295. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  296. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  297. Collin R, et al. 2014. J Immunol. 193:3503. PubMed
  298. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  299. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  300. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  301. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  302. Lv F, et al. 2022. iScience. 25:103639. PubMed
  303. Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed
  304. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  305. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  306. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  307. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  308. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  309. Yang H, et al. 2022. Nutrients. 14:. PubMed
  310. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  311. Huang YL, et al. 2021. Commun Biol. 4:229. PubMed
  312. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  313. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  314. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  315. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  316. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  317. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  318. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  319. Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed
  320. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  321. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  322. Shen X, et al. 2021. Front Immunol. 12:710750. PubMed
  323. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  324. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  325. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  326. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  327. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  328. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  329. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  330. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  331. Yang C, et al. 2013. Proc Natl Acad Sci U S A. 111:109. PubMed
  332. Du J, et al. 2018. AMB Express. 8:158. PubMed
  333. Cho K, et al. 2021. iScience. 24:103117. PubMed
  334. Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed
  335. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  336. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  337. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  338. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  339. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  340. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  341. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  342. Matsuo K, et al. 2018. J Immunol. 200:800. PubMed
  343. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  344. Andrade ACDSP, et al. 2021. J Virol. 95:e0127621. PubMed
  345. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  346. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  347. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  348. Liyanage S, et al. 2016. Exp Eye Res. 151:160-70. PubMed
  349. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  350. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  351. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  352. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  353. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  354. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  355. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  356. Nakamura Y, et al. 2015. Infect Immun . 83:671. PubMed
  357. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  358. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  359. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  360. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  361. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  362. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  363. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  364. Zhang H, et al. 2009. Invest Ophthalmol Vis Sci. 50:2653. PubMed
  365. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  366. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  367. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  368. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  369. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  370. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  371. Liu Y, et al. 2019. Sci Rep. 9:18970. PubMed
  372. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  373. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  374. Wang J, et al. 2019. Aging (Albany NY). 11:3463. PubMed
  375. Chen S, et al. 2022. iScience. 25:105176. PubMed
  376. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  377. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  378. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  379. Pantelidou C, et al. 2022. NPJ Breast Cancer. 8:102. PubMed
  380. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  381. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  382. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  383. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  384. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  385. Mahlios J, Zhuang Y 2011. Mol Immunol. 49:227. PubMed
  386. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  387. Klose R, et al. 2016. Nat Commun. 7:12528. PubMed
  388. Yomogida K, et al. 2013. Biochem Biophys Res Commun. 434:263. PubMed
  389. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  390. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  391. Li H, et al. 2022. iScience. 25:104481. PubMed
  392. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  393. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  394. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  395. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  396. Gao P, et al. 2021. Nat Commun. 1194:12. PubMed
  397. Yeon S, et al. 2017. Sci Rep. 10.1038/s41598-017-11492-7. PubMed
  398. Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed
  399. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  400. Pflügler S, et al. 2020. Commun Biol. 3:252. PubMed
  401. Rudd CE, et al. 2020. Cell Reports. 30(7):2075-2082. PubMed
  402. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  403. Petty AJ, et al. 2021. JCI Insight. 6:. PubMed
  404. Gawish R, et al. 2022. Elife. 11:. PubMed
  405. Kong IY, et al. 2020. Cell Rep. 33:108290. PubMed
  406. Fu W, et al. 2020. J Immunol Res. 8820355:2020. PubMed
  407. Sun J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:15:00. PubMed
  408. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  409. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  410. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  411. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  412. Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
  413. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  414. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  415. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  416. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
RRID
AB_312692 (BioLegend Cat. No. 100407)
AB_312693 (BioLegend Cat. No. 100408)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.
What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD4 Reagents Request Custom Conjugation
Description Clone Applications
APC/Cyanine7 anti-mouse CD4 GK1.5 FC
Brilliant Violet 711™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 510™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 605™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 785™ anti-mouse CD4 GK1.5 FC
PE/Dazzle™ 594 anti-mouse CD4 GK1.5 FC
APC/Fire™ 750 anti-mouse CD4 GK1.5 FC
GoInVivo™ Purified anti-mouse CD4 GK1.5 FC
Brilliant Violet 750™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 650™ anti-mouse CD4 GK1.5 FC
Spark Blue™ 550 anti-mouse CD4 GK1.5 FC
Spark NIR™ 685 anti-mouse CD4 GK1.5 FC
KIRAVIA Blue 520™ anti-mouse CD4 GK1.5 FC
APC/Fire™ 810 anti-mouse CD4 GK1.5 FC
PE/Fire™ 700 anti-mouse CD4 GK1.5 FC
PE/Fire™ 640 anti-mouse CD4 GK1.5 FC
APC anti-mouse CD4 GK1.5 FC
Biotin anti-mouse CD4 GK1.5 FC,IHC-F,ICC
FITC anti-mouse CD4 GK1.5 FC
PE anti-mouse CD4 GK1.5 FC
PE/Cyanine5 anti-mouse CD4 GK1.5 FC
Purified anti-mouse CD4 GK1.5 FC,IHC-F,ICC,IP,Costim,Block,Depletion
Alexa Fluor® 647 anti-mouse CD4 GK1.5 FC,IHC-F
Alexa Fluor® 488 anti-mouse CD4 GK1.5 FC,IHC-F
Alexa Fluor® 700 anti-mouse CD4 GK1.5 FC
Pacific Blue™ anti-mouse CD4 GK1.5 FC
PerCP anti-mouse CD4 GK1.5 FC
PerCP/Cyanine5.5 anti-mouse CD4 GK1.5 FC
Brilliant Violet 421™ anti-mouse CD4 GK1.5 FC,ICC,IHC-F
Ultra-LEAF™ Purified anti-mouse CD4 GK1.5 FC,Block,Costim,Depletion,IHC,IP
Alexa Fluor® 594 anti-mouse CD4 GK1.5 IHC-F,FC,SB
Spark Violet™ 538 anti-mouse CD4 GK1.5 FC
Spark YG™ 593 anti-mouse CD4 GK1.5 FC
Spark Blue™ 574 anti-mouse CD4 Antibody GK1.5 FC
Spark UV™ 387 anti-mouse CD4 GK1.5 FC
Spark Blue™ 515 anti-mouse CD4 GK1.5 FC
Spark PLUS UV395™ anti-mouse CD4 GK1.5 FC
Spark Red™ 718 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
PerCP/Fire™ 806 anti-mouse CD4 Antibody GK1.5 FC
PerCP/Fire™ 780 anti-mouse CD4 Antibody GK1.5 FC
StarBright UltraViolet 795 anti-mouse CD4 GK1.5 FC
Spark PLUS V475™ anti-mouse CD4 GK1.5 FC
Spark YG™ 581 anti-mouse CD4 (Flexi-Fluor™) GK1.5 FC
Spark PLUS B488™ anti-mouse CD4 GK1.5 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account